Publikationen der Mitarbeiter der Abteilung für Bakteriologie
1998-2006:
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
2007:
Originalien:
Thoms, K.-M., Zimmermann, O., Schupp, P., Thoms, S., and Emmert,
S. (2007). Nocardia otitisdiscaviarum: Cause of Long-term Cutaneous
Abscesses on the Leg of an Immunocompetent Man. Archives of
Dermatology 143: 1086-1087
2006:
Originalien:
Asif, A.R., Oellerich, M.,
Amstrong, V.W., Riemenschneider, B.,
Monod, M. and Reichard, U. (2006). Proteome
of Conidial Surface Associated Proteins of Aspergillus
fumigatus Reflecting Potential Vaccine Candidates and
Allergens. J Proteome Res 5: 954-962
Holpert,
M., U. Gross
and W. Bohne
(2006). Disruption of the bradyzoite-specific P-type (H+)-ATPase /PMA1/ in /Toxoplasma gondii/ leads to decreased bradyzoite
differentiation
after stress stimuli but does not interfere with mature tissue cyst
formation.
Mol. Biochem. Parasitol. 146:129-33
Keller, P.,
Schaumburg, F.,
Fischer, S. F.,
Hacker, G., Groß, U., and Lüder, C. G. K.
(2006)
Direct inhibition of cytochrome c-induced caspase activation in vitro
by Toxoplasma gondii reveals novel
mechanisms of interference with host cell apoptosis. FEMS Microbiol
Lett.
258:312-319.
Lang,
C., Algner, M., Beinert, N., Groß, U., Lüder, C.G. (2006). Diverse mechanisms employed by Toxoplasma gondii to inhibit
IFN-gamma-induced major histocompatibility complex class II gene
expression.
Microbes Infect. Jun 12; [Epub ahead of
print]
Lennon,
Á.M. ,
Buchalla, W L.
Brune, O. Zimmermann, U. Groß,
T. Attin. 2006. The ability of selected oral microorganisms to emit red
fluorescence.
Caries Res. 40: 2-5.
Lugert R, Schettler C,
Groß U (2006)
Comparison
of different protocols for DNA preparation and PCR for the detection of
fungal
pathogens in vitro. Mycoses 49:298-304.
Mirbod-Donovan,
F., Schaller, R., Hung, C.Y.,
Xue, J., Reichard, U. and Cole, G.T. (2006). Urease
Produced by
Coccidioides posadasii Contributes to the Virulence of This Respiratory
Pathogen. Infect. Immun. 74, 504-515
Reichard, U.,
Lechenne, B., Asif, A.R., Streit, F.,
Grouzmann, E., Jousson, O. and Monod, M. (2006). Sedolisins, a New
Class of
Secreted Proteases from Aspergillus fumigatus with Endoprotease or
Tripeptidyl-Peptidase Activity at Acidic pHs. Appl. Environ. Microbiol.
72,
1739-1748
Schmidt-Ott,
R.,
Schmidt, H., Feldmann,
S., Brass, F., Krone,
B., Groß, U. (2006). Improved serological diagnosis
stresses the major role of Campylobacter jejuni in triggering
Guillain-Barre
syndrome. Clin. Vaccine Immunol. 13: 779-83.
Asif,
Lennon,
A.M., Buchalla, W., Brune, L., Zimmermann, O., Gross, U. und Attin, T.
(2006). The ability of selected oral microorganisms to emit red
fluorescence. Caries Res 40:2-5.
Buchbeiträge
und Übersichten
Lüder, C.G.K. (2006). Survival strategies of Toxoplasma
gondii: Interference with
regulatory and effector functions of macrophages. In:
Denkers, E.Y. & Gazzinelli R.T. (Eds.). Protozoans
in macrophages. Landes Bioscience, Georgetown, USA. ISBN: 1-58706-085-X.
2005:
Originalien:
Denikus,
N., Orfaniotou, F., Wulf, G., Lehmann,
P.F., Monod, M. and Reichard, U. (2005). Fungal Antigens
Expressed
during Invasive Aspergillosis. Infect. Immun. 73, 4704-4713
Fasshauer,
V., U. Groß, and W. Bohne (2005). The
parasitophorous vacuole membrane of Encephalitozoon
cuniculi lacks host cell
membrane proteins
immediately after invasion. Eukaryotic Cell, 4:221-4.
Lüder,
C. G. K., and
Groß,
U.
(2005) Apoptosis and its modulation during infection with Toxoplasma
gondii: molecular mechanisms and role in pathogenesis.
Curr. Topics Microbiol. Immunol. 289:219-238.
Nierman,
W.C., Pain, A., Anderson, M.J.,
Wortman, J.R., Kim, H.S., Arroyo, J., Berriman, M., Abe, K., Archer,
D.B.,
Bermejo, C., Bennett, J., Bowyer, P., Chen, D., Collins, M., Coulsen,
R.,
Davies, R., Dyer, P.S., Farman, M., Fedorova, N., Feldblyum, T.V.,
Fischer, R.,
Fosker, N., Fraser, A., Garcia, J.L., Garcia, M.J., Goble, A., Goldman,
G.H.,
Gomi, K., Griffith-Jones, S., Gwilliam, R., Haas, B., Haas, H., Harris,
D.,
Horiuchi, H., Huang, J., Humphray, S., Jimenez, J., Keller, N., Khouri,
H.,
Kitamoto, K., Kobayashi, T., Konzack, S., Kulkarni, R., Kumagai, T.,
Lafton,
A., Latge, J.P., Li, W., Lord, A., Lu, C., Majoros, W.H., May, G.S.,
Miller,
B.L., Mohamoud, Y., Molina, M., Monod, M., Mouyna, I., Mulligan, S.,
Murphy,
L., O'Neil, S., Paulsen, I., Penalva, M.A., Pertea, M., Price, C.,
Pritchard,
B.L., Quail, M.A., Rabbinowitsch, E., Rawlins, N., Rajandream, M.A., Reichard,
U., Renauld, H., Robson, G.D., Rodriguez de Cordoba, S.,
Rodriguez-Pena,
J.M., Ronning, C.M., Rutter, S., Salzberg, S.L., Sanchez, M.,
Sanchez-Ferrero,
J.C., Saunders, D., Seeger, K., Squares, R., Squares, S., Takeuchi, M.,
Tekaia,
F., Turner, G., Vazquez de Aldana, C.R., Weidman, J., White, O.,
Woodward, J.,
Yu, J.H., Fraser, C., Galagan, J.E., Asai, K., Machida, M., Hall, N.,
Barrell,
B. and Denning, D.W. (2005). Genomic sequence of the pathogenic and
allergenic
filamentous fungus Aspergillus fumigatus.
Nature 438, 1151-1156
Schlott
T, Eiffert H, Bohne W, Landgrebe J, Brunner E,
Spielbauer B,
Knight B.
(2005). Chlamydia trachomatis
modulates expression of tumor suppressor gene caveolin-1 and oncogene
C-myc in
the transformation zone of non-neoplastic cervical tissue. Gynecol
Oncol.
98:409-19.
Schmidt-Ott,
R.,
Burghard, S., Pohl, S., Weig, M., and Groß, U. (2005) Identification and characterization of a
major subgroup of Campylobacter jejuni
plasmids. J. Infect. 50: 12-21.
Schmidt-Ott, R., Brass, F.,
Scholz, C.,
Werner, C., and Groß, U.
(2005) Improved serodiagnosis of Campylobacter jejuni
infections using recombinant antigens. J.
Med. Microbiol. 54: 761-767.
Zimmermann,
O.,
de Ciman, R., and Groß, U. (2005) Bacteremia
among Kenyan children (Correspondence).
N. Engl. J. Med. 352: 13
Nau,
R. und H. Eiffert
(2005). Minimizing the release of proinflammatory and toxic bacterial
products
within the host: a promising approach to improve outcome in
life-threatening
infections. FEMS Immunol Med Microbiol 44:1-16.
2004:
Originalien:
Spreer,
A., A. Lis, J.
Gerber, R.R. Reinert, H. Eiffert und R. Nau (2004). Differences in
clinical
manifestation of Streptococcus pneumoniae infection are not correlated
with in
vitro production and release of the virulence factors pneumolysin and
lipoteichoic/ teichoic acids. J. Clin. Microbiol. 42:3342-3345.
Wellmer,
A., M.v. Mering, A. Spreer, R. Diem, H. Eiffert,
C. Noeske, S. Bunkowski, R. Gold und R. Nau (2004). Experimental
pneumococcal
meningitis: Impaired clearance of bacteria from blood due to increased
apoptosis in the spleen in Bcl-2-deficient mice. Infect. Immun.
72:3113-3119.
Eiffert,
H., A. Karsten, T.
Schlott, A. Ohlenbusch, R. Laskawi, M. Hoppert und H.-J. Christen
(2004) Acute
peripheral facial palsy in Lyme Disease – a distal neuritis at the
infection
site. Neuropediatrics
35:267-273.
Buchbeiträge:
Christen,
H.-J. und H. Eiffert (2004). Infektionen des
zentralen Nervensystems. In: F. Aksu (Hrsg) Diagnostik und Therapie
neurologischer Erkrankungen im Kindesalter (2. Neubearb. Auflage).
UNI-MED,
Bremen, London, Boston (2004). S.335-353. (ISBN 3-89599-786-2)
Eiffert, H. und
R. Laskawi (2004). Klinik des
Botulismus. In: Botulinum -Toxin-Therapie im Kopf-Hals-Bereich (2.
aktualisierte und erweiterte Auflage) R. Laskawi und P.
Roggenkämper (Hrsg.),
Urban & Vogel, München (2004). S.20-25. (ISBN 3-89935-185-1)
2003:
Originalien:
Bakteriologie:
Spreer,
A., H. Kerstan, T.
Böttcher, J. Gerber, A. Siemer, T. Mitchell, H. Eiffert und R. Nau
(2003).
Reduced release of pneumolysin by Streptococcus
pneumoniae in vitro and in vivo after treatment with
nonbacteriolytic
antibiotics in comparison to ceftriaxone. Antimicro. Agents Chemother.
47:2649-2654.
Nagel,
H., R. Laskawi, H.
Eiffert und T. Schlott (2003). Analysis of the tumour suppressor
genes
FHIT and
WT-1 and the tumour rejection genes BAGE, GAGE-1, -2, HAGE, MAGE-1, and
MAGE-3
in benign and malignant neoplasms of the salivary glands. J. Clin.
Pathol.
56:226-231.
Strutz, F., A. Scheel,
M.
Koziolek, T. Kochsiek, H. Eiffert und G.A. Müller (2003).
„Eigentümliche
Infektion“ mit Fieber, Splenomegalie und akutem Nierenversagen bei
einem
24-jährigen Forstwirtschaftsstudenten. Internist 44:1575-1578.
Christen, H.-J. und H.
Eiffert (2003) Lyme-Borreliose: Haut- und Nervensystem. Monatschr.
Kinderheilk.
151:1146-1155.
Witte W., Rauterberg A., Zimmermann O., Braulke C., Cuny C.,
Groß
U. (2003) Are there community acquired MRSA in Central Europe? Abstract
RPoo8, Int J Med Microbiol 293:432.
Zutt, M., Zimmermann, O., Krüger, U. und Kretschmer, L.
(2003) Operative Sanierung florider venöser Ulzera. Phlebologie
32:121-6.
Lüder CGK, Algner M, Lang C, Bleicher N,
Groß U. (2003) Reduced expression of the inducible nitric
oxide synthase after infection with Toxoplasma gondii facilitates
parasite replication in activated murine macrophages. Int J Parasitol
33:833-844
Lüder CGK, Lang C, Giraldo-Velasquez M, Algner
M, Gerdes J, Groß U. (2003) Toxoplasma gondii inhibits MHC
class II expression in neural antigen-presenting cells by
down-regulating the class II transactivator CIITA. J Neuroimmunol
134:12-24
Lugert R, Kuhns M, Polch T, Groß U. (2003)
Expression and localization of type III secretion-related proteins of
Chlamydia pneumoniae. Med. Microbiol. Immunol., in press.
Nagel H, Laskawi R, Eiffert H, Schlott T (2003)
Analysis of the tumour suppressor genes FHIT and WT-1 and the tumour
rejection genes BAGE, GAGE-1, -2, HAGE, MAGE-1, and MAGE-3 in benign
and malignant neoplasms of the salivary glands. J Clin Pathol 56:226-231
Rostasy K, Reiber H, Pohl D, Lange P, Ohlenbusch A,
Eiffert H, Maass H, Hanefeld F (2003) Chlamydia pneumoniae in
children with MS: Frequency and quantity of intrathecal antibodies.
Neurology 61:125-129
Rüchel R, Dellmann A, Schaffrinski M, Donhuijsen K (2003)
Veinfachte Pilzdetektion. Der Pathologe (im Druck)
Spreer A, Kerstan H, Böttcher T, Gerber J,
Siemer A, Mitchell T, Eiffert H, Nau R (2003) Reduced release of
pneumolysin by Streptococcus pneumoniae in vitro and in vivo after
treatment with nonbacteriolytic antibiotics in comparison to
ceftriaxone. Antimicro Agents Chemother 47:2649-2654
Buchbeiträge und Übersichten:
Borg-von Zepelin M (2003) Labordiagnostik von Pilzinfektionen bei
immunsupprimierten Patienten In: Pilzinfektionen bei immunsupprimierten
Patienten Markus Ruhnke ed. UNI-MED Verlag, Bremen, pp. 100-108
Borg-von Zepelin M, Monod M (2003) Was passiert bei Pilzinfektionen auf
molekularer Ebene? Fungale Pathogene. Pharmazie in unserer Zeit
32:110-116
Christen H-J, Eiffert H (2003) Infektionskrankheiten durch
Spirochaeten. In: Pädiatrie.Grundlagen und Praxis. Lentze, M.J.,
J. Schaub, F.J. Schulte und J. Spranger (Hrsg.) Springer, Heidelberg
(2003). S. 690-696
Fierek O, Eiffert H, Laskawi R (2003) Die Rindertuberkulose beim
Menschen – Ein epidemiologischer Überblick und zwei Kasuistiken
von HNO-Manifestationen. In: Mitteilungen der Norddeutschen
Gesellschaft für Otorhinolaryngeologie und zervikofaziale
Chirurgie (2003)
S.53-54
Groß U (2003) Treatment of microsporidiosis
including albendazole. Parasitol Res 90:S14-S18
Hahn C, Borg-von Zepelin M, Groll AH, Lampe D , Schuler U,
Seibold M, Glasmacher A (2003) Standortbestimmung von
Antimykotika:
Itraconazol. Chemother J 12:85-92
Müller FM, Weig M (2003) Systemische Mykosen - Neue Ansätze
für Diagnostik und Therapie. Klinikarzt 32:53-60
Rüchel R (2003) Invasive Aspergillosen bei
hämatologisch-onkologischen Erkrankungen und Transplantation.
Bundesgesundheitsblatt 46:38-44
Schrod L, Bialek R, Döhring E, Groß U, Janitschke K, Prisa
A, Rossi R, Rudin C (2003) Toxoplasmose. In: Infektionen bei Kindern
und Jugendlichen. DGPI-Handbuch, 4. Auflage, Futuramed-Verlag
München, pp. 681-689
2002:
Originalien:
Azeh I, Gerber J, Wellmer A, Wellhausen M, Koenig
B, Eiffert H, Nau R (2002) The protein synthesis inhibiting
Clindamycin
improves outcome in a mouse model of staphylococcal sepsis to the cell
wall active Ceftriaxone. Crit Care Med 30:1560-1564
Blaschke S., Don M, Schillinger W, Rüchel R (2002)
Candida-Pneumonien ohne offenbare Immunsuppression. Mycoses 45
(Suppl. 3):22-26
Borg-von Zepelin M, Niederhaus T, Groß U,
Seibold M, Monod M, Tintelnot K (2002) Adherence of different
Candida dubliniensis isolates in the presence of fluconazole. AIDS
16:1237-1244
Borg-von Zepelin M, Zaschke K, Groß U, Monod M,
Müller FMC (2002) Effect of Micafungin (FK463) on Candida
albicans adherence to epithelial cells. Chemotherapy 48:148-153
Brenier-Pinchart MP, Vigan I, Jouvin-Marche E, Marche
PN, Pelet E, Groß U, Ambroise-Thomas P, Pelloux H
(2002) Monocyte chemotactic protein-1 secretion and expression after
Toxoplasma gondii infection in vitro depend on the stage of the
parasite. FEMS Microbiol Letters 214:45-49
Henke MO, de Hoog GS, Groß U, Zimmermann G,
Kramer D, Weig M (2002) Human deep tissue infection with an
entomopathogenic Beauveria species. J Clin Microbiol 40:2698-2707
Hung CY, Yu JJ, Seshan KR, Reichard U, Cole GT
(2002) A parasitic phase-specific adhesin of Coccidioides immitis
contributes to the virulence of this respiratory Fungal pathogen.
Infect Immun 70:3443-3456
Keller N, Naguleswaran A, Cannas A, Vonlaufen N,
Bienz M, Bjorkman C, Bohne W, Hemphill A (2002) Identification of a
Neospora caninum microneme protein (NcMIC1) which interacts with
sulfated host cell surface glycosaminoglycans. Infect Immun 70:3187-98
Monod M, Borg-von Zepelin M (2002) Secreted
aspartic proteases as virulence factors of Candida specied. Biol Chem
383:1087-1093
Müller FM, Trusen A, Weig M (2002) Clinical
manifestations and diagnosis of invasive aspergillosis in
immunocompromised
children. Eur J Pediatr 161:563-574
Nagl M, Gruber A, Fuchs A, Lell C, Lemberger EM,
Borg-von Zepelin M, Würzner R (2002) Impact of
N-chlorotaurine on viability and production of secreted aspartyl
proteinases of Candida. Antimicrob Agents Chemother 46:1996-1999
Ntefidou M, Elsner C, Spreer A, Weinstock N, Kratzin HD, Rüchel R
(2002) Beobachtungen zur Blutgerinnung bei einheimischen tiefen
Mykosen. Mycoses 45 (Suppl.1):53-56
Porras M, Martinez RH, Mones JC, Ares MA, Murguiondo MZ, Rüchel R
(2002) Fatal Aspergillus myocarditis following short-term
corticosteroid therapy for chronic obstructive pulmonary disease. Scand
J Infect
Dis 34:224-227
Rüchel R, Kellner S, Schaffrinski M (2002)
Renewed increase in Candida albicans among yeast isolates from the
Göttingen university hospital. Mycoses 45:109-110
Schlott T, Thasler W, Pahernik S, Goerzel C, Eiffert
H, Droese M (2002) Detection of MDM2 alterations in cultured human
hepatocytes treated with 17ß-estradiol or
17alpha-ethinylestradiol. Anticancer Res 22:1545-1552
Schoen C, Reichard U, Monod M, Kratzin HD,
Rüchel
R (2002) Molecular cloning of an extracellular aspartic proteinase
from Rhizopus microsporus and evidence for its expression during
infection.
Med Mycology 40:61-71
Vonlaufen N, Muller N, Keller N, Naguleswaran A,
Bohne W, McAllister MM, Bjorkman C, Muller E, Caldelari R,
Hemphill A (2002) Exogenous nitric oxide triggers Neospora caninum
tachyzoite-to-bradyzoite stage conversion in murine epidermal
keratinocyte cell cultures. Int J Parasitol 32:1253-65
Wellmer A, Zysk G, Gerber J, Kunst T, von Mering M,
Bunkowski S, Eiffert H, Nau R (2002) Decreased virulence of a
pneumolysin-deficient strain of Streptococcus pneumoniae in
murine meningitis. Infect Immun 70:6504-6508
Buchbeiträge und Übersichten:
Christen H-J, Eiffert H (2002) Infektionen des zentralen Nervensystems.
In: F. Aksu (Hrsg) Diagnostik und Therapie neurologischer Erkrankungen
im Kindesalter. UNI-MED, Bremen, London, Boston (2002). S.204-217
Monod M, Borg-von Zepelin M (2002). Secreted
proteinases and other virulence mechanisms of Candida albicans.
Chem Immunol 81:114-128
Nau R, Eiffert H (2002) Modulation of the release
of proinflammatory compounds by antibacterials – potential impact
on the course of inflammation and outcome in sepsis and meningitis.
Clin Microbiol Rev 15:95-110
2001:
Originalien:
Bekti J, Lell C, Fuchs A, Stoiber H, Speth
C, Lass-Flörl C, Borg-von Zepelin M, Dierich MP, Würzner R
(2001) HIV protease inhibitors attenuate adherence of Candida albicans
to epithelial cells in vitro FEMS Immunol Med Microbiol 31:65-71
Gail M, Groß U, Bohne W (2001)
Transcriptional
profile of Toxoplasma gondii-infected human fibroblasts as revealed
by gene-array hybridization. Mol Genet Genomics 265:905-912
Gerber J, Eiffert H, Fleischer H, Wellmer
A, Munzel U, Nau R (2001) Reduced release of DNA from
Streptococcus
pneumoniae after treatment with rifampin in comparison to spontaneous
growth and ceftriaxone treatment. Eur J Clin Microbiol Infect Dis
20:490-493
Goebel S, Groß U, Lüder CGK
(2001) Inhibition of host cell apoptosis by Toxoplasma gondii is
accompanied
by reduced activation of the caspase cascade and alterations of
poly(ADP-ribose)
polymerase expression. J Cell Science 114:3495-3505
Gratz S, Behe M, Boerman OC, Kunze E, Schulz
H, Eiffert H, O’Reilly T, Behr TM, Angerstein C, Nebendahl K, Kauer
F, Becker W (2001) 99m Tc-E-selectin binding peptide for imaging
acute osteomyelitis in a novel rat model. Nucl Med Commun 22:1003-1013
Holpert M, Lüder CGK, Groß U, Bohne
W (2001) Bradyzoite-specific expression of a P-type ATPase in
Toxoplasma
gondii. Mol Biochem Parasitol 112:293-296
Hung CY, Yu JJ, Seshan KR, Reichard U, Cole
GT (2002) A parasitic phase-specific adhesin of Coccidioides
immitis
contributes to the virulence of this respiratory Fungal pathogen.
Infect
Immun 70:3443-3456
Jouault T, Fradin C, Dzierszinski F, Borg-von-Zepelin
M, Tomavo S, Corman R, Trinel PA, Kerckaert JP, Poulain D (2001)
Peptides that mimic Candida albicans-derived beta-1,2-linked
mannosides.
Glycobiology 11:693-701
Kretschmer L, Zimmermann O, Stein A, Sebastian G (2001) Perioperative
Antibiotikatherapie in der Dermatologie. Leitlinie der Kommission
Qualitätssicherung der Deutschen Dermatologischen Gesellschaft und
des Berufsverbandes der Deutschen Dermatologen in Zusammenarbeit mit
der Vereinigung für Operative und Onkologische Dermatologie.
Hautarzt 52:609-614
Lüder CGK, Walter W, Beuerle B, Maeurer
MJ, Groß U (2001) Toxoplasma gondii down-regulates MHC class
II gene expression and antigen presentation by murine macrophages via
interference with nuclear translocation of STAT1 alpha. Eur J Immunol
31:1475-1484
Luty AJF, Ulbert S, Lell B, Lehman L, Schmidt-Ott
R, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Dubois B,
Deloron
P, Kremsner PG (2001) Antibody responses to Plasmodium falciparum:
Evolution according to the severity of a prior clinical episode and
association
with subsequent reinfection. Am J Trop Med Hyg 62:566-572
Müller FM, Weig M (2001) Clinical
Manifestations and Diagnosis of Invasive Aspergillosis in
Immunocompromised
Children, September (http://www.aspergillus.man.ac.uk
/secure/articles/EJpaed.html)
The Aspergillus Website (http://www.aspergillus.man.ac.uk), Editorial
board: David Denning, University of Manchester, John-Paul Latgé.
Institue Pasteur, John Pitt, Food Science Australia, Paul E. Verweij,
University Hospital Nijmegen.
Neumeister C, Nanan R, Cornu TI, Lüder CGK., terMeulen V, Naim H,
Niewiesk S (2001) Measles virus and canine distemper virus target
proteins into a TAP-independent MHC class I-restricted
antigen-processing pathway. J Gen Viro 82:441-447
Olusi TA, Weissbrich B, Ajayi JA, Groß U (2001) Coinfection
between HIV and Toxoplasma gondii. In: Petersen E, Pollak A,
Reiter-Owona I. Int J Parasitol 31:132-133
Robert A, Hedman K, Luyasu V, Zufferey J, Bessières
MH, Blatz RM, Candolfi E, Decoster A, Enders G, Groß U, Guy E,
Hayde M, Ho-Yen D, Johnson J, Lécollier B, Naessens A, Pelloux
H, Thulliez P, Petersen E (2001) Primary infection with Toxoplasma
gondii: a multicentre evaluation of serodiagnostic strategies. Eur
J Clin Microbiol Infect Dis 20:467-474
Schlott T, Nagel H, Laskawi R, Eiffert H, Droese M (2001) Genetic
analysis of the human oncoprotein MDM2 in benign and malignant tumors
of the salivary gland. Pathobiol 69:67-76.
Schlott T, Scharf J, Soruri A, Fayyazi A, Griesinger C, Eiffert H,
Droese M (2001) Fragments of human oncoprotein MDM2 reveal variable
distribution within and on cultivated human hepatoma cells. Biochem
Biophys Res Com 283:956-963
Schoen C, Reichard U, Monod M, Kratzin HD, Ruchel R (2002)
Molecular cloning of an extracellular aspartic proteinase from Rhizopus
microsporus and evidence for its expression during infection. Med
Mycol 40:61-71
Weig M, Frosch M, Tintelnot K, Haas A, Groß U, Linsmeier B,
Heesemann J (2001) Use of recombinant mitogillin for improved
serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin
Microbiol 39:1721-1730
Weig M, Groß U, Domhof S, Brunner E (2001) Use of recombinant
mitogllin for serodiagnosis of Aspergillus fumigatus-associated
diseases (author’s reply). J Clin Microbiol 39:4598-4600
Weig M, Haynes K, Kurzai O, Rogers T, Frosch M, Mühlschlegel F
(2001) The Candida glabrata CGG 1-3 gene family is required for growth
and morphogenesis. Microbiology147:2007-2019
Weig M, Müller FM (2001) Synergism of Voriconazole and Terbinafine
against Clinical Isolates of Candida albicans from HIV-infected
Patients suffering Oropharyngeal Candidiasis. Antimicrob Agents
Chemother 45:966-968
Wellmer A, Prange J, Gerber J, Lange P, Michel U, Eiffert H, Nau R
(2001) CSF lactate in bacterial meningitis originates predominantly
from host not from the microbes. Scand J Infect Dis 33:909-913
Zaugg C, Borg-Von Zepelin M, Reichard U, Sanglard D, Monod
M (2001) Secreted Aspartic Proteinase Family of Candida tropicalis.
Infect Immun 69:405-412
Buchbeiträge und Übersichten:
Christen H-J, Eiffert H (2001) Schwangerschaft und Lyme Borreliose –
häufige Fragen und Antworten. Nds Ärzteblatt 9:10-12
Groß U, Roos T, Friese K (2001) Toxoplasmose in der
Schwangerschaft. Dt Ärzteblatt 98:A3293-3300
Haase G, Borg-von Zepelin M, Bernhardt H, Fegeler W, Harmsen D, Kappe
R, Korting HC, Kuijpers A, Rüchel R, Schaller M, Schmalreck A,
Seebacher C, Tintelnot K In: Pilzinfektionen Teil I; Präanalytik,
Analytik. Qualitätsstandards in der
mikrobiologisch-infektiologischen Diagnostik, Urban und Fischer 14/ 2001
Haase G, Borg-von Zepelin M, Bernhardt H, Fegeler W, Harmsen D, Kappe
R, Korting HC, Kuijpers A, Rüchel R, Schaller M, Schmalreck A,
Seebacher C, Tintelnot K In: Pilzinfektionen Teil II; Spezielle
Pilzdiagnostik, Qualitätsstandards in der
mikrobiologisch-infektiologischen Diagnostik, Urban und Fischer 15/ 2001
Lüder CGK (2001) Analyse der Wirtszellveränderung durch
Toxoplasma gondii mittels konfokaler Laser-Scanning-Mikroskopie. GIT
Labor-Fachzeitschrift 9:934-936
Lüder CGK, Bohne W, Soldati D (2001) Toxoplasmosis: a
persisting challenge. Trends Parasitol 17:460-463
Lüder CGK, Groß U, Lopes MF (2001) Intracellular protozoan
parasites and apoptosis: diverse strategies to modulate parasite-host
interactions. Trends Parasitol 17:480-486
Lüder CGK, Seeber F (2001) Toxoplasma gondii and MHC-restricted
antigen presentation: on degradation, transport and modulation. Int
J. Parasitol 31:1355-1369
Müller FM, Weig M (2002) Manifestations and Diagnosis
of Invasive Aspergillosis in Immunocompromised Children. Eur J Pediat
161:563-74.
Rüchel R, Behe M, Torp B, Laatsch H (2001) Usefulness
of optical brighteners in medical mycology. Rev Iberoamericana.
Micologia 18:147-149
Schütt-Gerowitt H, Rüchel R (2001) Spezielle medizinische
Mykologie. In: Köhler W, Eggers HJ, Fleischer B, Marre R, Pfister
H, Pulverer G (Hrsg.) Medizinische Mikrobiologie. München: Urban
u. Fischer, pp. 681-698
Weig M, Reichard U, Groß U (2001) Aspergillus fumigatus –
virulence and opportunism? Mycoses 44:351-355
2000:
Originalien:
Andreas S, Heindl S, Wattky C, Möller K, Rüchel R
(2000) Diagnosis of pulmonary aspergillosis using optical brighteners.
Eur Respirat J 15:407-411
Beggah S, Lechenne B, Reichard U, Foundling S, Monod M (2000) Intra-
and intermolecular events direct the propeptide-mediated maturation of
the Candida albicans secreted aspartic proteinase Sap1p. Microbiology
146:2765-2773
Binder C, Rüchel R (2000) Mixed systemic mycosis with fatal
outcome in a patient with acute myeloblastic leukaemia. Mycoses
43:49-53
Bohne W, Ferguson DJP, Kohler K, Groß U (2000) Developmental
expression of a tandemly repeated, glycine- and serine-rich spore wall
protein in the microsporidian pathogen Encephalitozoon cuniculi. Infect
Immun 68: 2268-2275
Fein M, Fuchs KH, DeMeester TR, Peters JH, Wittmann D, Weig
M (2000) Evaluation of the intestinal microflora in the rat model for
esophageal adenocarcinoma. Dis Esophag 13:39-43
Groß U, Lüder CGK, Hendgen V, Heeg C, Sauer I, Weidner A,
Krczal D, Enders G (2000) Comparative IgG-antibody profile between
mother and child (CGMC test) for diagnosis of congenital toxoplasmosis.
J Clin Microbiol 38:3619-3622
Luty AJF, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D,
Greve B, Matousek P, Herbich K, Schmid D, Weinberg JB, Kremsner
PG (2000) Low interleukin-12 activity in severe Plasmodium falciparum
malaria. Infect Immun 68:3909-3915
Müller FM, Weig M, Peter J, Walsh TJ (2000) Azole Cross-Resistance
to Ketoconazole, Fluconazole, Itraconazole and Voriconazole in Clinical
Candida albicans Isolates from HIV-Infected Children with Oropharyngeal
Candidiasis, J Antimicrob Chemother46:338-340
Reiter-Owona I, Seitz H, Groß U, Sahm M, Rockstroh JK, Seitz HM
(2000) Is stage conversion the initiating event for reactivation of
Toxoplasma gondii in brain tissue of AIDS patients. J Parasitol
86:531-536
Reichard U, Cole GT, Hill TW, Rüchel R, Monod M (2000)
Molecular characterization and influence on fungal development of ALP2,
a novel serine proteinase from Aspergillus fumigatus. Int J Med
Microbiol
290:549-558
Reichard U, Cole GT, Rüchel R, Monod M (2000) Molecular cloning
and targeted deletion of PEP2 which encodes a novel aspartic proteinase
from Aspergillus fumigatus. Int J Med Microbiol 290:85-96
Reichard U, Hung CY, Thomas PW, Cole GT (2000) Disruption of the gene
which encodes a serodiagnostic antigen and chitinase of the human
fungal pathogen Coccidioides immitis. Infect Immun 68:5830-5838
Rüchel R, Schaffrinski M, Seshan KR, Cole GT (2000) Vital staining
of fungal elements in deep seated mycotic lesions during experimental
mycoses using the parenterally applied optical brightener Blankophor.
Med Mycology 38:231-237
Wilke M, Eiffert H, Christen H-J, Hanefeld F (2000) Primarily chronic
and cerebro-vascular course of Lyme neuroborreliosis: Case
reports and literature review. Arch Dis Child. 83:67-71
Buchbeiträge und Übersichten:
Christen H.-J, Eiffert H (2000) Infektionskrankheiten durch
Spirochaeten. In: Pädiatrie.Grundlagen und Praxis. Lentze, M.J.,
J. Schaub, F.J. Schulte und J. Spranger (Hrsg.) Springer, Heidelberg
(2000). S. 690-696
Groß U (2000) Toxoplasmose, mta Spektrum 15:228-232
Groß U (2000) Parasiten: Erreger-Wirt-Beziehung, Allgemeine
Pathogenese. In: Marre R, Mertens T, Trautmann M, Vanek E (eds.),
Klinische Infektiologie, Urban und Schwarzenberg, München, pp.
33-42
Groß U, Pelloux H (2000) Diagnosis in the pregnant woman. In:
Ambroise-Thomas P, Petersen E (eds.), Congenital toxoplasmosis,
Springer, Paris, pp. 121-130
Ponton J, Rüchel R, Clemons KV, Coleman DC, Grillot R,
Guarro J, Aldeberts D, Ambroise-Thomas P, Cano J, Carillo-Munoz AJ,
Gene J, Pinel C, Stevens DA, Sullivan DJ (2000) Emerging
pathogens.
Med Mycology 38 (Suppl.1):225-236
Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB,
Stanek G (2000) MIQ Lyme-Borreliose. In: Mauch, H., Lütticken,
R. und S. Gatermann (eds.) Qualitätsstandards in der
mikrobiologisch-infektiologischen Diagnostik. Urban & Fischer,
München, Jena (2000). 1-59
Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB,
Stanek G (2000) MIQ Lyme Borreliosis. In: Mauch, H., R. Lütticken
and S. Gatermann (eds.) Quality Standards for the Microbiological
Diagnosis of Infectious Diseases.
http://alpha1.mpk.med.uni-muenchen.de/bak/nrz-borrelia/miq-lyme/index.html
1999:
Originalien:
Borg-von Zepelin M, Meyer I, Thomssen R, Sanglard D, Telenti A, Monod M
(1999) HIV protease inhibitors reduce cell adherence of
Candida albicans strains by inhibition of yeast secreted aspartic
proteases. J Invest Dermatol 113:747-751
Goebel S, Lüder CGK, Groß U (1999) Invasion by Toxoplasma
gondii protects human-derived HL-60 cells from actinomycin D-induced
apoptosis. Med Microbiol Immunol 187:221-226
Greve B, Lehman LG, Lell B, Luckner D, Schmidt-Ott R, Kremsner PG
(1999) High oxygen radical production is associated with fast clearance
in children with Plasmodium falciparum malaria. J Infect Dis
179:1584-1586
Gruber A, Berlit J, Speth C, Lass-Flörl C, Kofler G, Nagl M,
Borg-von Zepelin M, Dierich MP, Wurzner R. (1999) Dissimilar
attenuation of Candida albicans virulence properties by human
immunodeficiency virus type 1 protease inhibitors. Immunobiology
201:133-44
Gruber A, Speth C, Lukasser-Vogl E, Zangerle R, Borg-von Zepelin M,
Dierich MP, Würzner R (1999) Human immunodefiency virus type 1
protease inhibitor attenuates Candida albicans properties in vitro
Immunopharmacology 41:227-234
Hermann C, Hermann J, Munzel U, Rüchel R (1999) Bacterial flora
accompanying Candida yeasts in clinical specimens. Mycoses 42:619-627
Jäckel M C, Witt O, Eber S W, Eiffert H, Laskawi R (1999) Die
postoperative antibiotische Therapie von zervikalen Lymphadenitiden
durch nichttuberkulöse, atypische Mykobakterien. Laryngo Rhino
Otol 78:450-454
Kambouris ME, Reichard U, Legakis NJ, Velegraki A (1999) Sequences from
the aspergillopepsin PEP gene of Aspergillus fumigatus: evidence on
their use in selective PCR identification of Aspergillus species
in infected clinical samples. FEMS Immunol Med Microbiol 25:255-264
Kempf MC, Cesbron-Delauw MF, Deslée D, Groß U, Herrmann T,
Sutton P (1999) Different manifestations of Toxoplasma gondii
infection in rat strains. Med Microbiol Immunol 187:137-142
Kun JFJ, Lehman L, Lell B, Schmidt-Ott R, Kremsner PG (1999) Low-dose
treatment with sulfadoxine-pyrimethamine combinations selects for
drug-resistant Plasmodium falciparum strains. Antimicrob Agents
Chemother 43:2205-2208
Lell B, May J, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek
P, Schmid D, Herbich K, Mockenhaupt FP, Meyer CG, Bienzle
U, Kremsner PG (1999) The role of red blood cell polymorphism in
resistance and susceptibility to malaria. Clin Infect Dis 28:794-799
Lorf T, Braun F, Rüchel R, Müller A, Sattler B, Ringe B
(1999) Systemic mycoses during prophylactical use of liposomal
amphotericin (Ambisome) after liver transplantation. Mycoses 42:47-53
Lüder CGK, Giraldo-Velàsquez M, Sendtner M, Groß U
(1999) Toxoplasma gondii in primary rat CNS cells: Differential
contribution of neurons, astrocytes and microglial cells for the
intracerebral development and stage differentiation. Exp Parasitol
93:23-32
Luty AJF, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B,
Matousek P, Herbich K, Schmid D, Migot-Nabias F, Deloron P, Nussenzweig
RS, Kremsner PG (1999) Interferon-gamma responses are associated with
resistance to reinfection with Plasmodium falciparum in young African
children. J Infect Dis 179:980-988
Martius JA, Roos T, Gora B, Oehler MK, Schrod L, Papadopoulos T,
Groß U (1999) Risk factors associated with early-onset sepsis in
premature infants. Eur J Obstet Gynecol Reprod Biol 85:151-158
Monod M, Borg-von Zepelin M, Telenti A, Sanglard D (1999) The
inhibition of Candida albicans secreted aspartic proteases by three
different HIV protease inhibitors. Dermatology 198:412-414
Reiter-Owona I, Petersen E, Joynson D, Aspöck H, Dardé ML,
Disko R, Dreazen O, Dumon H, Grillo R, Groß U, Hayde M, Holliman
R, Ho-Yen DO, Janitschke K, Jenum P, Naser K, Olszewski M, Thulliez
P, Seitz HM (1999) The past and present role of the Sabin-Feldman dye
test in the serodiagnosis of toxoplasmosis. Bull WHO 77:929-935
Ricard J, Pelloux H, Favier AL, Groß U, Brambilla E,
Ambroise-Thomas P (1999) Toxoplasma gondii: Role of
phosphatidylcholine-specific
phospholipase C during cell invasion and intracellular development.
Exp Parasitol 91:231-237
Ricard J, Pelloux H, Groß U, Meunier A, Ambroise-Thomas P (1999)
Induction of Toxoplasma gondii cystogenesis and multiplication arrest
by treatments with a phosphatidylcholine-specific phospholipase C
inhibitor. J Parasitol 85:583-585
Richter D, Endepols S, Ohlenbusch A, Eiffert H, Spielman A, Matuschka
F-R (1999) Genospecies diversity of Lyme disease spirochetes in
reservoir rodents. Emerg Infect Dis 5:291-296
Rüchel R, Mergeryan H, Boger O, Langefeld C, Witte W (1999)
Outbreak of methicillin-resistant Staphylococcus aureus in a german
tertiary-care hospital. Infect. Control Hosp Epidemiol 20:353-355
Rüchel R, Schaffrinski M (1999) Versatile fluorescent
staining of fungi in clinical specimens using the optical brightener
Blankophor. J Clin Microbiol 37:2694-2696
Sauter A, Eiffert H, Bommer W (1999) Lyme-Borreliose: Erregersuche in
Zecken aus der Region um Manaus (Brasilien). Mitt Österr Ges
Tropenmed Parasitol 21:39-44
Schaller M, Korting HC, Hube B, Schäfer W, Borg-von Zepelin M,
Thoma-Grebe E, Ollert M (1999). Evidence for In vivo expression
of Candida albicans secreted aspartyl proteinases in oropharyngeal
candidiasis by immunoelectron microscopy and rt-pcr. J Invest Dermatol
112:383-386
Sobanjo BAO, Ferguson DJP, Groß U (1999) Primary acquired
toxoplasmosis in a five-year old child with perinatal human
immunodeficiency virus type 1 infection. Ped Infect Dis J 18:477-479
Soboslay PT, Lüder CGK, Riesch S, Geiger SM, Banla M,
Batchassi E, Stadler A, Schulz-Key H (1999) Regulatory effects of
Th1-type
(IFN-, IL-12) and Th2-type cytokines (IL-10, IL-13) on
parasite-specific
cellular responsiveness in Onchocerca volvulus-infected humans and
exposed endemic controls. Immunology 97:119-225
Stuertz K, Schmidt H, Trostdorf F, Eiffert H, Mäder M, Nau R
(1999) Lower lipoteichoic and teichoic acid concentrations during
treatment of experimental pneumococcal meningitis with
non-bacteriolytic antibiotics moxifloxacin, trovafloxacin, rifabutin,
and quinopristin-dalfopristin than during ceftriaxone therapy. Scand J
Infect Dis 31:367-370
Südkamp M, Eiffert H, Lissel C, Flesch M, Böhm M,
Mehlhorn U, Thomssen R, de Vivie E R (1999) Cardiac myocytes of
hearts from patients with end-stage dilated cardiomyopathy do not
contain Borrelia burgdorferi DNA. Am Heart J 138:269-272
Weig M, Werner E, Frosch M, Kasper H (1999) Limited effect
of refined carbohydrate dietary supplementation on colonization of
the gastrointestinal tract of healthy volunteers by Candida albicans,
Am J Clin Nutr 69:1170-1173
Witt O, Jäckel M, Eiffert H, Laskawi R, Eber S (1999)
Therapie der Lymphadenitis colli durch atypische Mykobakterien nach
inkompletter chirurgischer Sanierung. Monatsschr Kinderheilkd
147:648-651
Zimmermann O (1999) Nachweis der Clostridium difficile assoziierten
Diarrhoe. Der Internist 40: 884
Buchbeiträge und Übersichten:
Bohne W, Holpert M, Groß U (1999) Stage differentiation of the
protozoan parasite Toxoplasma gondii. Immunobiol 201:248-254
Eiffert H., Laskawi R (1999) Klinik des Botulismus. In: Botulinum
-Toxin-Therapie im Kopf-Hals-Bereich. R. Laskawi und P.
Roggenkämper (Hrsg.), Urban & Vogel, München (1999) 6-11
Groß U, Reichard U (1999) Pränatale Toxoplasmose –
Möglichkeiten und Grenzen der mikrobiologischen Diagnostik.
Mikrobiologe 9:121-124
Groß U, Schwarzkopf A, Sefrin P, Karch H (1999) Infektionshygiene
im Rettungsdienst. In: Sefrin P (ed.), Notfalltherapie (6.
Auflage), Urban und Schwarzenberg, München, pp. 257-262
Hube B, Rüchel R, Monod M, Sanglard D, Odds FC (1998)
Functional aspects of secreted Candida proteinases. Adv Exp Med
Biol 436:339-344
Monod M, Jaton-Ogay K, Reichard U (1999) Aspergillus fumigatus secreted
proteases as antigenic molecules and virulence factors. In: Brakhage A,
Jahn B, Schmidt A (eds) Aspergillus fumigatus. Biology, Clinical
Aspects and Molecular Approaches to Pathogenicity, vol 2. Karger AG,
Basel, pp 182-192
Rüchel R (1999) Proteinasen pathogener Pilze. Mycoses
42 (Suppl.1):48-52
Rüchel R (1999) An overview of fungal pathogens of
ophthalmological importance. In: Behrens-Baumann W (ed.) Mycosis of the
eye and its adnexa. Basel: Karger pp. 1-26
Rüchel R, Reichard U (1999) Pathogenesis and clinical
presentation of aspergillosis. In: Brakhage A, Jahn B, Schmidt A (eds)
Aspergillus fumigatus. Biology, Clinical Aspects and Molecular
Approaches
to Pathogenicity, vol 2. Karger AG, Basel, pp 21-43
Vente C, Rupprecht R, Junghans V, Günzl H-J, Hallermann C, Eiffert
H, Kolde G, Neumann C (1999) Borrelia burgdorferi-Infektion unter dem
klinischen Bild multipler Retikulohistiozytome. Hautarzt (50) Suppl.
1:60-62
Weig M, Karch H, Mühlschlegel F (1999) Pilze im Darm - Fakten,
Fragen, Forschungsbedarf, in Ökosystem Darm VIII, Th. Kist-M
(Hrsg.), Sringer-Verlag, Berlin, Heidelberg: 65-74
1998:
Originalien:
Bohne W, Hunter CA, White MW, Ferguson DJP, Groß U, Roos DS
(1998) Targeted disruption of the bradyzoite-specific gene BAG1 does
not prevent tissue cyst formation in Toxoplasma gondii. Mol Biochem
Parasitol 92:291-301
Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M (1998) The
expression of the secreted aspartyl proteinases Sap4 to Sap6 from
Candida albicans in murine macrophages. Mol Microbiol 28:543-554.
Braun F, Rüchel R, Lorf T, Canelo R, Müller
A, Sattler B, Ringe B (1998) Is liposomal amphotericin B
(Ambisome) an effective prophylaxis after liver transplantation?
Transplantation Proceedings 30:1481-1483
Eiffert H, Karsten A, Thomssen R, Christen H-J (1998) Characterization
of B. burgdorferi strains in Lyme arthritis. Scand J Infect Dis
30:265-268
Ferguson DJP, Alexander J, Walker W, Groß U, Bohne W,
Spenter H, Petersen E (1998) An immunocytochemical study of stage
conversion (tachyzoite/bradyzoite) of Toxoplasma gondii in SCID mice.
Proceeding of EUREM-96, Vol 3:411-412, Committee of European Societies
of Microscopy, Brussels.
Groß U, Bednarek I, Frosch M (1998) Antibiotic resistance in
Salmonella enterica serotype Typhimurium. Eur J Clin Microbiol Infect
Dis 17:385-387
Gruber A, Lukasser-Vogl E, Borg-von Zepelin M, Dierich MP, Würzner
R (1998) Human immunodefiency virus type 1 gp160 and gp41 binding to
Candida albicans selectively enhances Candida virulence in vitro. J
Infect Dis 177:1057-1063
Jerome ME, Radke JR, Bohne W, Roos DS, White MW (1998) Toxoplasma
gondii bradyzoites form spontaneously during sporozoite-initiated
development. Infect Immun 66:4838-4844
Karvar S, Burghardt W, Groß U (1998) Immunoblot assay
for detection of salivary antibodies directed against
Helicobacter pylori. Gut 42:900.
Kern W, Braess J, Bertz H, Pott C, Schleyer J, Rüchel,
R, Hiddemann W (1998) Chronic systemic aspergillosis in a patient
with acute myeloid leukemia. Ann Hematol 76:175-177
Kun J, Schmidt-Ott R, Lehman L, Lell B, Luckner D, Greve B,
Matousek P, Kremsner PG (1998) Merozoite surface antigens 1 and 2
genotypes
and rosetting of Plasmodium falciparum in severe and mild malaria in
Lambarene Gabon. Trans Royal Soc Trop Med Hyg 92:110-114
Lell B, Schmidt-Ott JR, Lehmann LG, Stürchler D, Handschin J,
Kremsner PG (1998) Malaria chemotherapy trial at minimal effective dose
of mefloquine/sulfadoxine/pyrimethamine or mefloquine alone. Am J Trop
Med Hyg 58:619-624
Luckner D, Lell B, Greve B, Lehman L, Schmidt-Ott R, Matousek P,
Herbich K, Schmid D, Mba R, Kremsner PG (1998) No influence of
socioeconomic factors on severe malarial anaemia hyperparasitaemia or
reinfection. Trans Royal Soc Trop Med Hyg 92:478-481
Lüder CGK, Lang T, Groß U (1998) Down-regulation
of MHC class II molecules on murine macrophages after infection with
Toxoplasma gondii. Clin Exp Immunol 112:308-316
Luty AJF, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B,
Matousek P, Herbich K, Schmid D, Ulbert S, Migot-Nabias F, Dubois B,
Deloron P, Kremsner PG (1998) Parasite antigen-specific interleukin-10
and antibody responses predict accelerated parasite clearance in
Plasmodium falciparum malaria. Eur Cytok Netw 9:639-646
Reichard U (1998) The significance of secretory and
structure-associated proteases of Aspergillus fumigatus for the
pathogenesis of invasive aspergillosis. Mycoses 41:78-82
Sahm M, Groß U, Reiter-Owona I, Seitz HM (1998) Infection and
stage conversion during murine pulmonary toxoplasmosis: a study
with three different strains of Toxoplasma gondii. J Parasitol
84:723-729
Schmidt-Ott R, Klenner T, Overath P, Aebischer T (1998) Topical
treatment with Hexadecylphosphocholine (Miltex) efficiently reduces
parasite burden in experimental cutaneous Leishmaniasis. Transactions
of the Royal Society of Tropical Medicine and Hygiene 93:85-90
Seeber F, Ferguson DJP, Groß U (1998) Toxoplasma gondii: A
paraformaldehyde-insensitive diaphorase activity acts as a specific
histochemical marker for the single mitochondrion. Exp Parasitol
89:137-139
Singer S, Singer D, Rüchel R, Mergeryan H, Schmidt U, Harms K
(1998) Outbreak of systemic aspergillosis in a neonatal intensive care
unit. Mycoses 41:223-227
Singer S, Singer D, Stöhr G, Rüchel R, Rothe H, Harms K
(1998) Mukormykose als Ursache einer nekrotisierenden Enterokolitis.
Monatsschr Kinderheilkd 146:26-29
Stuertz H, Merx I, Eiffert H, Schmutzhard E, Mäder M, Nau R (1998)
Enzyme immunoassay detecting teichoic and lipoteichoic acids versus
cerebrospinal fluid culture and latex agglutination for the diagnosis
of Streptococcus pneumoniae meningitis. J Clin Microbiol 36:2346-2348
Stuertz H, Schmidt H, Eiffert H, Schwarz P, Mäder M, Nau R
(1998) Differential release of teichoic and lipoteichoic acids from
Streptococcus pneumoniae by ß-lactam antibiotics, rifamycins,
trovafloxacin, and quinupristin/dalfopristin. J Antimicrob Agents
Chemother 42:277-281
Wulf GG, Reichard U, Wörmann B, Hiddemann W (1998) Pneumocystis
carinii pneumonia with peripheral nodular infiltrates in a patient with
T-acute lymphoblastic leukemia. J Clin Oncol 16:3476-3477
Zimmermann O, Sproer C, Kroppenstedt R M, Fuchs E, Köchel H G,
Funke G (1998) Corynebacterium thomssenii sp.nov., a Corynebacterium
with N-acetyl-beta-glucosaminidase activity from human clinical
specimens. Int J Syst Bacteriol 48: 489-94
Buchbeiträge und Übersichten:
Bohne W, Groß U (1998) Toxoplasma gondii - Strategien
eines erfolgreichen Parasiten. Biospektrum 4:27-31
Janitschke K, Kimmig P, Seitz HM, Frosch M, Groß U, Hlobil H,
Reiter-Owona I (1998) MIQ - Parasitosen. Gustav Fischer Verlag,
Stuttgart.
Lüder CGK, Groß U (1998) Toxoplasmosis: from clinics to
basic science. Parasitol Today 14:43-45
Petry F, Groß U (1998) Kryptosporidiose und Mikrosporidiose bei
Immunschwäche. Fortschr Med 116:29-31
Rüchel R (1998) Diagnostik von tiefen Mykosen. In: Kujath P (Hrsg)
Mykosen in der operativen Medizin. Berlin: Blackwell, pp. 17–23
Rüchel R, Reichard U (1998) Pathogenesis and clinical presentation
of aspergillosis. In: Brakhage AA, Jahn B, Schmidt A (eds.) Aspergillus
fumigatus. Basel: Karger, pp.21-43
Weig M, Groß U, Mühlschlegel F (1998) Clinical aspects and
pathogenesis of Candida infection. Trends Microbiol 6:468-470
Angela Aurin-Gerke, 07.09.2007
Zurück zur Startseite